Jorge Darcourt

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

Samuel A. Shelburne, Fehmida Visnegarwala, Jorge Darcourt et al. · AIDS · 2005 · 633 citations

Immunology, Inflammation, Clinical Epidemiology +19

The Role of Immune Reconstitution Inflammatory Syndrome in AIDS‐Related<i>Cryptococcus neoformans</i>Disease in the Era of Highly Active Antiretroviral Therapy

Samuel A. Shelburne, Jorge Darcourt, A. Clinton White et al. · Clinical Infectious Diseases · 2005 · 307 citations

Primary Immunodeficiency, Inflammation, Human Immunodeficiency Virus +14

Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic

Jorge Darcourt, Kalia Aparicio, Phillip M. Dorsey et al. · JCO Oncology Practice · 2020 · 119 citations · Full text

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer

Andrew W. Chung, Kartik Anand, Ann C. Anselme et al. · Science Translational Medicine · 2021 · 102 citations

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

Tejal Patel, Joe Ensor, Sarah L. Creamer et al. · Breast Cancer Research · 2019 · 65 citations · Full text